secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0000313143-23-000039
Event type: earnings
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics Q1 fiscal 2024 results announced; press release text not available
------------------------------------------------------------------------------

- Filing states Haemonetics issued a press release on Aug 8, 2023 for Q1 ended July 1, 2023.
- No specific financial metrics (revenue, EPS, guidance) are provided in the extracted text.
- Confidence low: cannot confirm actual performance numbers from this filing excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314323000039/0000313143-23-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314323000039/hae-20230808.htm
  HTML page:      https://secwatch.observer/filing/0000313143-23-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer